Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue
Abstract
Introduction: Hepatitis C virus (HCV) infection is a worldwide problem and hepatitis, which is its natural unfavourable course, is still a challenge for hepatologist. At present, standards of treatment are changing from combined therapy with interferon alpha (IFN-α) and ribavirin to new antiviral drugs. The current classification divides interferon induced thyroid diseases (IITD) into two groups: autoimmune (Hashimoto disease, Graves disease, positive antithyroid autoantibodies in euthyroid patients) and non-autoimmune (destructive thyroiditis, non-autoimmune hypothyroidism). A common complication of cytokine therapy is the induction of antithyroid autoantibodies de novo without thyroid dysfunction. During therapeutic regimens combined with ribavirin, destructive thyroiditis with typical biphasic course is more common than in IFN-α monotherapy. Clinically, overt pathologies often have discrete symptoms, which cause diagnostic and therapeutic dilemmas. Aims: The aim of this study was to estimate IITD occurrence, to find risk factors for IITD development. Material and methods: The study group consisted of 66 patients treated for HCV infection. Before and during antiviral therapy, hormonal (TSH, fT4, fT3), immunological (thyroid autoantibodies), ultrasonographic and genetic (HLA-A2) parameters were evaluated. Results: Hormonal disturbances were detected in 24.2% of patients; however, 43.9% of patients had positive thyroid autoantibodies (de novo) without hormonal imbalance. Multivariate analysis revealed the following: female sex, elevated TSH level, occurrence of anti-TPO autoantibodies (TPO-Ab), and increased blood velocity in thyroid arteries are risk factors for IITD development. In conclusion: Thyroid disorders are common during IFN-α therapy. Previous epidemiological data seem to be underestimated. Important risk factors for IITD development are: female sex, elevated serum TSH concentration (≥2.5 μU/mL), positive TPO-Ab and increased blood velocity in thyroid arteries.
Authors and Affiliations
Łukasz Obołończyk, Małgorzata Siekierska-Hellmann, Piotr Wiśniewski, Anna Lewczuk, Monika Berendt-Obołończyk, Zofia Michalska, Danuta Radowska, Grażyna Moszkowska, Agnieszka Bianek-Bodzak, Krzysztof Sworczak
Młodzieńcze idiopatyczne zapalenie stawów a stan jamy ustnej
Młodzieńcze idiopatyczne zapalenie stawów (MIZS) jest najczęstszą autoimmunologiczną zapalną chorobą tkanki łącznej w wieku rozwojowym. Charakteryzuje się postępującą destrukcją stawów, powodującą różnego stopnia utrwalo...
Guz chromochłonny w ciąży
Guz chromochłonny (pheochromocytoma) występuje z częstością szacowaną na 2-7 na 100 000 ciężarnych. Nierozpoznany, i tym samym nieleczony, wiąże się z bardzo wysoką śmiertelnością okołoporodową matek i płodów (40-50%). G...
Stearoyl-CoA desaturase – the lipid metabolism regulator
Stearoyl-CoA desaturase is an enzyme from the class of oxidoreductase, which catalyzes the formation of a fatty acid double bond between C9 and C10. It plays a key role in composition of the fatty acid profile in adipose...
Wielofazowość antygenów rzęskowych u pałeczek Salmonella
U pałeczek Salmonella obserwuje się więcej niż jedną fazę antygenów rzęskowych, co jest uwarunkowane występowaniem jednego, dwóch lub trzech genów, które niezależnie od siebie kodują białko strukturalne witki rzęski o w...
Cardiotoxicity as undesired side effect in the treatment of breast cancer
Improvement of methods used in breast cancer therapy resulted in increased treatment effectiveness and prolonged survival of patients. However, this is accompanied by increased frequency of adverse side effects, includin...